Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-15 to 2025-03-14
Current total value of award: $593572
Description: TARGETING THE A2B ADENOSINE RECEPTOR FOR IMMUNOPREVENTION OF PANCREATIC CANCER